[2-(2,6-dimethylanilino)-2-oxoethyl]-diethyl-(phenylmethyl)ammonium has been researched along with Nasal Polyps in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Adappa, ND; Arnold, M; Bosso, JV; Civantos, AM; Cohen, NA; Colquitt, LR; Cowart, BJ; Gleeson, PK; Kohanski, MA; Lin, C; Maina, IW; Palmer, JN; Reed, DR; Stevens, EM; Tan, LH | 1 |
Adappa, ND; Brooks, SG; Carey, RM; Chen, B; Cohen, NA; Hatten, KM; Kennedy, DW; Lee, RJ; Palmer, JN; Siebert, AP; Workman, AD | 1 |
2 other study(ies) available for [2-(2,6-dimethylanilino)-2-oxoethyl]-diethyl-(phenylmethyl)ammonium and Nasal Polyps
Article | Year |
---|---|
Denatonium benzoate bitter taste perception in chronic rhinosinusitis subgroups.
Topics: Chronic Disease; Humans; Nasal Polyps; Quaternary Ammonium Compounds; Rhinitis; Sinusitis; Taste Perception | 2021 |
Denatonium-induced sinonasal bacterial killing may play a role in chronic rhinosinusitis outcomes.
Topics: Antimicrobial Cationic Peptides; Bacteriolysis; Calcium Signaling; Cell Growth Processes; Cells, Cultured; Chronic Disease; Cilia; Disease Progression; Endoscopy; Female; Humans; Immunity, Innate; Male; Nasal Polyps; Pseudomonas aeruginosa; Pseudomonas Infections; Quaternary Ammonium Compounds; Rhinitis; Sinusitis; Treatment Outcome | 2017 |